Walleye Capital LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $932,940 - $1.27 Million	73,000 Added 104.43%	142,900 $2.32 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $485,485 - $656,565	45,500 Added 186.48%	69,900 $986,000
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $112,867 - $147,757	13,900 Added 132.38%	24,400 $254,000
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $32,912 - $47,080	4,400 Added 72.13%	10,500 $107,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $43,920 - $57,767	6,100 New	6,100 $45,000
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $300,468 - $523,409	43,800 New	43,800 $353,000
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $1.47 Million - $2.96 Million	-219,800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $1.13 Million - $1.86 Million	-173,600 Reduced 44.13%	219,800 $2.15 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $2.18 Million - $3.39 Million	353,200 Added 878.61%	393,400 $2.71 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $189,195 - $366,276	-23,300 Reduced 36.69%	40,200 $371,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $989,330 - $1.27 Million	63,500 New	63,500 $996,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.